Reunion Neuroscience Inc 's

• REUN's Stock Performance relative to its Competitors

Akili Inc Share Performance -0.62% Over The Past 5 Days

Akili Inc Profile Akili Inc is a technology-based healthcare company that develops digital therapeutics to treat cognitive disorders. Their business model revolves around creating and commercializing clinically validated video games and mobile apps, which serve as non-pharmacological treatments for conditions like ADHD and autism. More about Akili Inc 's Market Share

Compass Pathways Plc Share Performance -6.77% This Quarter

Compass Pathways Plc Profile Compass Pathways Plc is a mental healthcare company focused on developing innovative therapies for treatment-resistant depression. They are pioneering the use of psychedelic-assisted therapy to address this significant unmet medical need. With a business model centered around clinical research and drug development, their goal is to bring their therapies to market and improve the lives of patients suffering from depression. More about Compass Pathways Plc's Market Share

Definium Therapeutics Inc Share Performance -8.08% 30 Days

Definium Therapeutics Inc Profile Definium Therapeutics develops pharmaceutically optimized psychedelic drug candidates. More about Definium Therapeutics Inc 's Market Share

Karuna Therapeutics Inc Share Performance +3.33% Over The Past 5 Days

Karuna Therapeutics Inc Profile Karuna Therapeutics Inc's business model revolves around developing innovative therapies for neuropsychiatric disorders by leveraging the potential of its proprietary platform, targeting the muscarinic cholinergic receptors in the brain. More about Karuna Therapeutics Inc 's Market Share

Sage Therapeutics Inc Share Performance -20.73% One Year

Sage Therapeutics Inc Profile Sage Therapeutics Inc's business model primarily revolves around researching, developing, and commercializing innovative therapies for various central nervous system disorders. The company focuses on discovering novel molecules and applying them to create targeted treatments that address the unmet medical needs of patients. By harnessing scientific advancements and strategic collaborations, Sage aims to deliver transformative therapies for individuals suffering from conditions such as depression, postpartum depression, and other mood disorders. More about Sage Therapeutics Inc 's Market Share

Sources: Reunion Neuroscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 1:19 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Reunion Neuroscience Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.